Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed b…
Official notice from a government agency or its published feed.
Reason: Labeling: Label Mix-up
Class IIIThe lowest FDA recall level: unlikely to cause health problems, but it breaks the rules. · Ongoing · US Nationwide.
Hazard: Labeling: Label Mix-up
View the FDA enforcement report ↗ ← All reports